ctrl K

Price Alert

Aerpio Pharmaceuticals In... (ARPO)

NASDAQ: ARPO · Real-Time Price · USD

2.20

-0.02 (-0.90%)

At close: Aug 27, 2021, 6:00 AM

Aerpio Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021
Revenue	25.98M	5.51M	4.47M
Cost of Revenue	n/a	35.02M	20.02M
Gross Profit	n/a	-29.51M	-15.54M
Operating Income	-67.46M	-36.95M	-23.82M
Interest Income	3.92M	29K	59K
Pretax Income	-63.69M	-36.92M	-23.16M
Net Income	-63.69M	-36.92M	-23.16M
Selling & General & Admin	36.75M	7.44M	8.28M
Research & Development	51.03M	35.02M	20.02M
Other Expenses	5.66M	n/a	n/a
Operating Expenses	93.44M	7.44M	7.55M
Interest Expense	-154K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	n/a	42.45M	27.57M
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	27.03M	34.29M	24.1M
Shares Outstanding (Diluted)	27.03M	34.29M	24.1M
EPS (Basic)	-2.36	-1.08	-0.96
EPS (Diluted)	-2.36	-1.08	-0.96
EBITDA	-67.46M	-36.05M	-22.65M
EBIT	n/a	-36.95M	-23.82M
Depreciation & Amortization	n/a	892K	1.17M